Search research articles
Contact Us
Filters
Showing results (181-190 of 418) with videos related to
Page
of 42
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
May 25, 2023
Ipilimumab plus nivolumab in patients with symptomatic melanoma brain metastasis requiring corticosteroids
Simona Manacorda, Maria De Toro Carmena, Ciara Malone, et al.
European Urology Open Science
|
March 4, 2022
Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 Countries
Rachel Giles, Deborah Maskens, Robert Bick, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 30, 2025
Impact of the Type of Dialysate Acid Concentrate Container on the Environmental Footprint of Hemodialysis Centers
Rodrigo Martínez Cadenas, Julia Audije-Gil, María Dolores Arenas, et al.
Plos Medicine
|
November 20, 2024
Economic, cultural, and social inequalities in potentially inappropriate medication: A nationwide survey- and register-based study in Denmark
Amanda Paust, Claus Vestergaard, Susan M Smith, et al.
European Radiology
|
September 28, 2022
Optimisation of b-values for the accurate estimation of the apparent diffusion coefficient (ADC) in whole-body diffusion-weighted MRI in patients with metastatic melanoma
Annemarie K Knill, Matthew D Blackledge, Andra Curcean, et al.
Anticancer Research
|
July 2, 2014
A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experience
Charlotte Benson, Joanna Vitfell-Rasmussen, Marco Maruzzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 4, 2011
Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma
John M Kirkwood, Lars Bastholt, Caroline Robert, et al.
BMC Nephrology
|
May 21, 2026
Greener dialysis in practice: life cycle assessment of sustainable practice changes in haemodialysis care
Abass Fehintola, Maaike K Van Gelder, A A F Crooijmans, et al.
Current Oncology Reports
|
September 24, 2024
Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated Cardiotoxicity
Isabelle Senechal, Maria Sol Andres, Jieli Tong, et al.
Pigment Cell & Melanoma Research
|
June 11, 2014
The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis
Simon J Furney, Samra Turajlic, Gordon Stamp, et al.
Page
of 42
Search research articles
Search
Showing results (181-190 of 418) with videos related to
Sort By:
Page
of 42
European Journal of Cancer (Oxford, England : 1990)
|
May 25, 2023
Ipilimumab plus nivolumab in patients with symptomatic melanoma brain metastasis requiring corticosteroids
Simona Manacorda, Maria De Toro Carmena, Ciara Malone, et al.
European Urology Open Science
|
March 4, 2022
Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 Countries
Rachel Giles, Deborah Maskens, Robert Bick, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 30, 2025
Impact of the Type of Dialysate Acid Concentrate Container on the Environmental Footprint of Hemodialysis Centers
Rodrigo Martínez Cadenas, Julia Audije-Gil, María Dolores Arenas, et al.
Plos Medicine
|
November 20, 2024
Economic, cultural, and social inequalities in potentially inappropriate medication: A nationwide survey- and register-based study in Denmark
Amanda Paust, Claus Vestergaard, Susan M Smith, et al.
European Radiology
|
September 28, 2022
Optimisation of b-values for the accurate estimation of the apparent diffusion coefficient (ADC) in whole-body diffusion-weighted MRI in patients with metastatic melanoma
Annemarie K Knill, Matthew D Blackledge, Andra Curcean, et al.
Anticancer Research
|
July 2, 2014
A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experience
Charlotte Benson, Joanna Vitfell-Rasmussen, Marco Maruzzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 4, 2011
Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma
John M Kirkwood, Lars Bastholt, Caroline Robert, et al.
BMC Nephrology
|
May 21, 2026
Greener dialysis in practice: life cycle assessment of sustainable practice changes in haemodialysis care
Abass Fehintola, Maaike K Van Gelder, A A F Crooijmans, et al.
Current Oncology Reports
|
September 24, 2024
Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated Cardiotoxicity
Isabelle Senechal, Maria Sol Andres, Jieli Tong, et al.
Pigment Cell & Melanoma Research
|
June 11, 2014
The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis
Simon J Furney, Samra Turajlic, Gordon Stamp, et al.
Page
of 42